May Influence Pain and Stress Response Pathways Some studies suggest DSIP may interact with pathways involved in pain perception and stress response, making it relevant in neurobiological research focused on central nervous system adaptability and resilience
For example, some diabetic patients who experience gastrointestinal side effects from standard doses of GLP-1 receptor agonists may benefit from a slower dose escalation to reduce discomfort
If side effects are problematic, your doctor can discuss alternatives, including: Dose adjustment or slower titration Switching to a different GLP-1 receptor agonist Alternative diabetes medications with different mechanisms of action Additional treatments to manage specific symptoms According to NICE guidance on type 2 diabetes management (NG28), treatment decisions should be individualised, balancing efficacy, side effects, patient preferences, and overall quality of life
BPC-157 Description: BPC-157 is a synthetic 15-amino-acid peptide (stable gastric pentadecapeptide) originally identified in association with proteins present in gastric juice
335,336 The expression of iNOS is primarily activated by the NF-B pathway, which is activated and translocated to the nucleus upon inflammatory stimulation (such as bacterial endotoxins or pro-inflammatory cytokines), thus increasing the transcription and expression of iNOS
In particular, tell your provider if you have or have a past history of: Type 1 or type 2 diabetes Thyroid cancer Pancreatitis Kidney disease Diabetic retinopathy Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding